Background: The hepatoprotective potential of Phellinus linteus polysaccharide (PLP) extracts has been described. However, the molecular mechanism of PLP for the inhibition of liver fibrosis is unclear. This study aims to investigate the molecular protein signatures involved in the hepatoprotective mechanisms of PLP via a proteomics approach using a thioacetamide (TAA)-induced liver fibrosis rat model. Methods: Male Sprague-Dawley rats were divided into three groups of six as follows: Normal group; TAA group, in which rats received TAA only; and PLP group, in which rats received PLP and TAA. Liver fibrosis was induced in the rats by repeated intraperitoneal injections of TAA at a dose of 200 mg/kg body weight twice a week for 4 weeks. PLP w...
<p>Liver fibrosis is a common pathological feature of many chronic liver diseases. Bupleurum margina...
<p>Liver fibrosis is a common pathological feature of many chronic liver diseases. Bupleurum margina...
In the dimethylnitrosamine (DMN)-induced hepatic fibrosis Wistar rat model, the mycelium extract of ...
Background: The hepatoprotective potential of Phellinus linteus polysaccharide (PLP) extracts has be...
Abstract Background The hepatoprotective potential of Phellinus linteus polysaccharide (PLP) extract...
Background: The hepatoprotective potential of Phellinus linteus polysaccharide (PLP) extracts has be...
polysaccharide extracts against thioacetamide-ats: a proteomics analysis Conclusion: The proteomics ...
Edible and medicinal fungi are one of the major sources for extraction and identification of polysac...
Phellinus linteus (PL) mushroom has been reported to possess antioxidant activity. The present study...
AIM: This study was aimed to determine the antifibrotic activity of Phaleria macrocarpa (PM) extract...
<p>Liver fibrosis is a common pathological feature of many chronic liver diseases. Bupleurum margina...
<p>Liver fibrosis is a common pathological feature of many chronic liver diseases. Bupleurum margina...
Hepatic fibrosis is a consequence of chronic liver diseases. Metalloproteinase and its inhibitor hav...
<p>Liver fibrosis is a common pathological feature of many chronic liver diseases. Bupleurum margina...
<p>Liver fibrosis is a common pathological feature of many chronic liver diseases. Bupleurum margina...
<p>Liver fibrosis is a common pathological feature of many chronic liver diseases. Bupleurum margina...
<p>Liver fibrosis is a common pathological feature of many chronic liver diseases. Bupleurum margina...
In the dimethylnitrosamine (DMN)-induced hepatic fibrosis Wistar rat model, the mycelium extract of ...
Background: The hepatoprotective potential of Phellinus linteus polysaccharide (PLP) extracts has be...
Abstract Background The hepatoprotective potential of Phellinus linteus polysaccharide (PLP) extract...
Background: The hepatoprotective potential of Phellinus linteus polysaccharide (PLP) extracts has be...
polysaccharide extracts against thioacetamide-ats: a proteomics analysis Conclusion: The proteomics ...
Edible and medicinal fungi are one of the major sources for extraction and identification of polysac...
Phellinus linteus (PL) mushroom has been reported to possess antioxidant activity. The present study...
AIM: This study was aimed to determine the antifibrotic activity of Phaleria macrocarpa (PM) extract...
<p>Liver fibrosis is a common pathological feature of many chronic liver diseases. Bupleurum margina...
<p>Liver fibrosis is a common pathological feature of many chronic liver diseases. Bupleurum margina...
Hepatic fibrosis is a consequence of chronic liver diseases. Metalloproteinase and its inhibitor hav...
<p>Liver fibrosis is a common pathological feature of many chronic liver diseases. Bupleurum margina...
<p>Liver fibrosis is a common pathological feature of many chronic liver diseases. Bupleurum margina...
<p>Liver fibrosis is a common pathological feature of many chronic liver diseases. Bupleurum margina...
<p>Liver fibrosis is a common pathological feature of many chronic liver diseases. Bupleurum margina...
In the dimethylnitrosamine (DMN)-induced hepatic fibrosis Wistar rat model, the mycelium extract of ...